MYOCARDIAL CONTRACTILE FUNCTION IN PATIENTS WITH LIVER CIRRHOSIS AND SYNDROME OF BACTERIAL OVERGROWTH SYNDROME

被引:1
作者
Ivashkin, K., V [1 ]
Shirokova, E. N. [1 ]
Ivashkin, V. T. [1 ]
Plyusnin, S., V [2 ]
Zharkova, M. S. [1 ]
Maslennikov, R., V [1 ]
Skhirtladze, M. R. [1 ]
Maevskaya, M., V [1 ]
机构
[1] Sechenov Univ, Sechenov Moscow State Med Univ 1, Moscow, Russia
[2] Minist Def Russia, Cent Mil Clin Hosp 3, Moscow, Moscow Region, Russia
关键词
liver cirrhosis; heart failure; bacterial overgrowth syndrome; serum-ascitic albumin gradient; brain natriuretic peptide (BNP); proBNP; BRAIN NATRIURETIC PEPTIDE; CONSENSUS CONFERENCE; ASCITES; RECOMMENDATIONS; MANAGEMENT; DIAGNOSIS; SEVERITY; FAILURE;
D O I
10.18087/cardio.2019.4.10252
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: to study myocardial contractile function in patients with liver cirrhosis and ascites in the presence of bacterial overgrowth syndrome (BOS) and pathological bacterial translocation. Materials and methods. We included in this study 59 patients with Child-Pugh class B and C liver cirrhosis (LC) of various etiology and ascites. Control group comprised 12 patients with ischemic heart disease complicated by chronic heart failure (CHF). Examination included history taking and laboratory and instrumental investigation. LC was diagnosed basing on clinical symptoms and instrumental studies. Child-Pugh and MELD scores were used for assessment of LC severity and prognosis. International ascites club grading system was used for evaluation of severity of ascites. Hydrogen breath test was applied for diagnosing BOS. Syndrome of pathological bacterial translocation was established based on blood levels of lipopolysaccharide-binding protein and detection of bacterial DNA in ascitic fluid. Structural-functional parameters of the myocardium and hemodynamics were assessed by echocardiography. Brain natriuretic peptide (BNP) concentration was measured in blood serum and ascitic fluid. Results. In 13 of 59 patients with LC the hydrogen breath test was negative, in 33 positive and in 13 patients the positive hydrogen test was combined with the presence of BOS and pathological bacterial translocation. Blood serum and ascitic fluid BNP concentrations in LC patients were low and within normal limits (62.5 +/- 4.1 and 53.3 +/- 4.9 rg /ml, respectively), what contrasted with high BNP concentrations in patients with CHF (1820 +/- 95.5 and 497.1 +/- 39.6 rg/ml, respectively). Total protein level in ascitic fluid also was significantly lower in patients with LC than in patients with CHF (1.77 +/- 0.1 and 4.43 +/- 0.35 mg/ dL, respectively). The serum-ascitic albumin gradient (SAAG) in both groups of patients exceeded 1.1 (1.58 +/- 0.13 in patients with CHF and 1.88 +/- 0.19 in patients with LC). Conclusions. In patients with liver cirrhosis the presence of BOS and bacterial translocation did not produce a distinct negative impact on contractile function.
引用
收藏
页码:67 / 73
页数:7
相关论文
共 21 条
  • [1] [Anonymous], 2006, STAT ANAL MED DATA A
  • [2] Treatment of portal hypertension
    Bari, Khurram
    Garcia-Tsao, Guadalupe
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (11) : 1166 - 1175
  • [3] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [4] Braunwald E, 2001, HARRISONS PRINCIPLES, P91
  • [5] B-type natriuretic peptide in cardiovascular disease
    de Lemos, JA
    McGuire, DK
    Drazner, MH
    [J]. LANCET, 2003, 362 (9380) : 316 - 322
  • [6] Serum B-Type Natriuretic Peptide in the Initial Workup of Patients With New Onset Ascites: A Diagnostic Accuracy Study
    Farias, Alberto Q.
    Silvestre, Odilson M.
    Garcia-Tsao, Guadalupe
    da Costa Seguro, Luis F. B.
    de Campos Mazo, Daniel F.
    Bacal, Fernando
    Andrade, Jose L.
    Goncalves, Luciana L.
    Strunz, Celia
    Ramos, Danusa S.
    Polli, Demerson
    Pugliese, Vincenzo
    Rodrigues, Ana C. T.
    Furtado, Meive S.
    Carrilho, Flair J.
    D'Albuquerque, Luiz A. C.
    [J]. HEPATOLOGY, 2014, 59 (03) : 1043 - 1051
  • [7] A prognostic model for predicting survival in cirrhosis with ascites
    Fernández-Esparrach, G
    Sánchez-Fueyo, A
    Ginès, P
    Uriz, J
    Quintó, L
    Ventura, PJ
    Cárdenas, A
    Guevara, M
    Sort, P
    Jiménez, W
    Bataller, R
    Arroyo, V
    Rodés, J
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 (01) : 46 - 52
  • [8] Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease
    Henriksen, JH
    Gotze, JP
    Fuglsang, S
    Christensen, E
    Bendtsen, F
    Moller, S
    [J]. GUT, 2003, 52 (10) : 1511 - 1517
  • [9] Recommendations for chamber quantification
    Lang, Roberto M.
    Bierig, Michelle
    Devereux, Richard B.
    Flachskampf, Frank A.
    Foster, Elyse
    Pellikka, Patricia A.
    Picard, Michael H.
    Roman, Mary J.
    Seward, James
    Shanewise, Jack
    Solomon, Scott
    Spencer, Kirk T.
    Sutton, Martin St. John
    Stewart, William
    [J]. EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY, 2006, 7 (02): : 79 - 108
  • [10] State of the art: Using natriuretic peptide levels in clinical practice
    Maisel, Alan
    Mueller, Christian
    Adams, Kirkwood, Jr.
    Anker, Stefan D.
    Aspromonte, Nadia
    Cleland, John G. F.
    Cohen-Solal, Alain
    Dahlstrom, Ulf
    DeMaria, Anthony
    Di Somma, Salvatore
    Filippatos, Gerasimos S.
    Fonarow, Gregg C.
    Jourdain, Patrick
    Komajda, Michel
    Liu, Peter P.
    McDonagh, Theresa
    McDonald, Kenneth
    Mebazaa, Alexandre
    Nieminen, Markku S.
    Peacock, W. Frank
    Tubaro, Marco
    Valle, Roberto
    Vanderhyden, Marc
    Yancy, Clyde W.
    Zannad, Faiez
    Braunwald, Eugene
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (09) : 824 - 839